These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 23582055)
41. The development and early clinical testing of the ExPEC4V conjugate vaccine against uropathogenic Escherichia coli. Huttner A; Gambillara V Clin Microbiol Infect; 2018 Oct; 24(10):1046-1050. PubMed ID: 29803843 [TBL] [Abstract][Full Text] [Related]
42. How to make it in the urinary tract: a tutorial by Escherichia coli. Jorgensen I; Seed PC PLoS Pathog; 2012; 8(10):e1002907. PubMed ID: 23055921 [No Abstract] [Full Text] [Related]
43. The effect of nitric oxide on adherence of P-fimbriated uropathogenic Escherichia coli to human renal epithelial cells. Svensson L; Säve S; Persson K BJU Int; 2010 Jun; 105(12):1726-31. PubMed ID: 19863519 [TBL] [Abstract][Full Text] [Related]
44. Detrimental role for CCAAT/enhancer binding protein δ in blood-borne brain infection. Duitman J; Valls Serón M; Engelen-Lee J; Brouwer MC; Spek CA; van de Beek D BMC Infect Dis; 2016 Nov; 16(1):670. PubMed ID: 27835970 [TBL] [Abstract][Full Text] [Related]
45. Virulence profiles in uropathogenic Escherichia coli isolated from pregnant women and children with urinary tract abnormalities. Poey ME; Albini M; Saona G; Laviña M Microb Pathog; 2012 May; 52(5):292-301. PubMed ID: 22406645 [TBL] [Abstract][Full Text] [Related]
46. [Escherichia coli alpha-hemolysin antibodies in urinary tract infection]. Galiński J; Nowicki B; Hebanowski M; Manitius A Pol Tyg Lek; 1981 Jul; 36(28):1051-3. PubMed ID: 7031622 [No Abstract] [Full Text] [Related]
47. Comparison of virulence variations on MDCK monolayers by Escherichia coli isolated from acute lobar nephronia and acute pyelonephritis. Cheng CH; Su LH; Tsau YK; Lin TY New Microbiol; 2011 Jan; 34(1):65-72. PubMed ID: 21344148 [TBL] [Abstract][Full Text] [Related]
48. Kicking Out Pathogens in Exosomes. Sergeeva OA; van der Goot FG Cell; 2015 Jun; 161(6):1241-2. PubMed ID: 26046431 [TBL] [Abstract][Full Text] [Related]
49. A TRP Channel Senses Lysosome Neutralization by Pathogens to Trigger Their Expulsion. Miao Y; Li G; Zhang X; Xu H; Abraham SN Cell; 2015 Jun; 161(6):1306-19. PubMed ID: 26027738 [TBL] [Abstract][Full Text] [Related]
50. Recent advances in the molecular basis of pathogen recognition and host responses in the urinary tract. Schilling JD; Hultgren SJ; Lorenz RG Int Rev Immunol; 2002; 21(4-5):291-304. PubMed ID: 12486816 [No Abstract] [Full Text] [Related]
52. Metformin strengthens uroepithelial immunity against E. coli infection. Majhi RK; Mohanty S; Kamolvit W; White JK; Scheffschick A; Brauner H; Brauner A Sci Rep; 2021 Sep; 11(1):19263. PubMed ID: 34584119 [TBL] [Abstract][Full Text] [Related]
53. Infection: Siderophore-based vaccine protects against E. coli infection. Sidaway P Nat Rev Urol; 2017 Feb; 14(2):67. PubMed ID: 27898097 [No Abstract] [Full Text] [Related]
54. CCAAT/enhancer-binding protein δ: multifaceted regulator in respiratory disease. Duitman JW; Hoogendijk AJ; van der Poll T; Spek CA Am J Pathol; 2013 Apr; 182(4):1459. PubMed ID: 23499053 [TBL] [Abstract][Full Text] [Related]
55. Re: Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells. Schaeffer EM J Urol; 2016 Oct; 196(4):1141-2. PubMed ID: 27628801 [No Abstract] [Full Text] [Related]
56. C/EBPδ: friend or foe? a novel role for C/EBPδ in metastasis. Pelorosso FG; Balmain A EMBO J; 2010 Dec; 29(24):4063-5. PubMed ID: 21157479 [TBL] [Abstract][Full Text] [Related]
57. [On the presence of specific antibodies in urinary tract infections due to enterococci]. ROEMER GB; MAI K Z Hyg Infektionskr; 1961; 147():246-56. PubMed ID: 13742690 [No Abstract] [Full Text] [Related]
58. Why are diabetics prone to kidney infections? Zasloff M J Clin Invest; 2018 Dec; 128(12):5213-5215. PubMed ID: 30418173 [TBL] [Abstract][Full Text] [Related]